Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Morgensztern

Showing results (171-180 of 184) with videos related to

Pageof 19
Sort By:
Nature Medicine|June 1, 2026
SEZ6-targeting antibody-drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trialLauren Averett Byers, Byoung Chul Cho, Alissa J Cooper, et al.
Nature Medicine|June 29, 2026
Author Correction: SEZ6-targeting antibody-drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trialLauren Averett Byers, Byoung Chul Cho, Alissa J Cooper, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 17, 2018
NCCN Guidelines Insights: Small Cell Lung Cancer, Version 2.2018Gregory P Kalemkerian, Billy W Loo, Wallace Akerley, et al.
The New England Journal of Medicine|March 25, 2026
Setidegrasib in Advanced Non-Small-Cell Lung Cancer and Pancreatic CancerWungki Park, Anup Kasi, Alexander I Spira, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 10, 2025
NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 7.2025Gregory J Riely, Douglas E Wood, Dara L Aisner, et al.
Nature Medicine|February 13, 2024
Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trialBenjamin Besse, Elvire Pons-Tostivint, Keunchil Park, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 9, 2026
Non-Small Cell Lung Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In OncologyGregory J Riely, Douglas E Wood, Dara L Aisner, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 5, 2021
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021David S Ettinger, Douglas E Wood, Dara L Aisner, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 11, 2022
Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in OncologyDavid S Ettinger, Douglas E Wood, Dara L Aisner, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 4, 2023
NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 2.2023David S Ettinger, Douglas E Wood, Dara L Aisner, et al.
Pageof 19

Showing results (171-180 of 184) with videos related to

Sort By:
Pageof 19
Nature Medicine|June 1, 2026
SEZ6-targeting antibody-drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trialLauren Averett Byers, Byoung Chul Cho, Alissa J Cooper, et al.
Nature Medicine|June 29, 2026
Author Correction: SEZ6-targeting antibody-drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trialLauren Averett Byers, Byoung Chul Cho, Alissa J Cooper, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 17, 2018
NCCN Guidelines Insights: Small Cell Lung Cancer, Version 2.2018Gregory P Kalemkerian, Billy W Loo, Wallace Akerley, et al.
The New England Journal of Medicine|March 25, 2026
Setidegrasib in Advanced Non-Small-Cell Lung Cancer and Pancreatic CancerWungki Park, Anup Kasi, Alexander I Spira, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 10, 2025
NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 7.2025Gregory J Riely, Douglas E Wood, Dara L Aisner, et al.
Nature Medicine|February 13, 2024
Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trialBenjamin Besse, Elvire Pons-Tostivint, Keunchil Park, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 9, 2026
Non-Small Cell Lung Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In OncologyGregory J Riely, Douglas E Wood, Dara L Aisner, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 5, 2021
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021David S Ettinger, Douglas E Wood, Dara L Aisner, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 11, 2022
Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in OncologyDavid S Ettinger, Douglas E Wood, Dara L Aisner, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 4, 2023
NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 2.2023David S Ettinger, Douglas E Wood, Dara L Aisner, et al.
Pageof 19